APOA5 and coronary artery disorder: In addition, a significant dose-dependent association has been reported between the APOA5 −1131T>C polymorphism and the risk of coronary heart disease in an analogous dose-dependent manner, with about an 18% higher risk per C allele, providing evidence for a causal association between TG-mediated pathways and coronary heart disease [28].